<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7309518\results\search\testTrace\results.xml">
  <result pre="GBS but other autoimmune neurological diseases necessitating vigilance for early" exact="diagnosis" post="and therapy initiation. Although COVID-19 infection, like most other"/>
  <result pre="had lymphocytopenia and high C-reactive protein (CRP) that led to" exact="diagnosis" post="of COVID-19. One patient had facial diplegia and sensory"/>
  <result pre="reporting sudden loss of smell and taste early in the" exact="infection" post="in up to 60% of COVID-19 carriers5,6,12 is highly"/>
  <result pre="enter the brain via olfactory nerves.13 In mice, after oronasal" exact="infection" post="with SARS-CoV, the virus not only infects epithelial cells"/>
  <result pre="was not detected in the CSF, implying no direct root" exact="infection" post="or intrathecal viral replication. The improvement of several patients"/>
  <result pre="(AIDP, AMAN, and MFS) can be expected with COVID-19, necessitating" exact="screening" post="for ganglioside antibodies to assess autoimmunity. An interesting therapeutic"/>
  <result pre="has been likely overlooked. Studies with muscle biopsy and antibody" exact="screening" post="are urgently needed in such patients because therapy with"/>
  <result pre="medical staff, vigilance for these disorders is needed along with" exact="screening" post="for autoimmune encephalitis autoantibodies14 because these cases can potentially"/>
  <result pre="with MS where it seems safe to start or continue" exact="treatment" post="with the standard disease-modifying drugs. If clinically stable and"/>
  <result pre="if any, effect on suppressing the innate immunity that facilitates" exact="infection" post="of macrophages and viral spread. Similar data from New"/>
  <result pre="that complement inhibition may alleviate the inflammatory complications of COVID-19" exact="infection" post="leading to ongoing trials with anti-C3 and anti-C5 agents.41,42"/>
  <result pre="BlakeA, MonsS, et al.Guillain-Barre syndrome outbreak associated with Zika virus" exact="infection" post="in French Polynesia: a case-control study. Lancet2016;387:1531â€&quot;1539.26948433 4.ZhuN, ZhangD,"/>
  <result pre="collab: For the PATH Study Group. Subcutaneous immunoglobulin for maintenance" exact="treatment" post="in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind,"/>
  <result pre="for neurology. Neurology2008;70:2252â€&quot;2260.18519875 39.FanM, QiuW, BuB, et al.Risk of COVID-19" exact="infection" post="in MS and neuromyelitis optica spectrum disorders. Neurol Neuroimmunol"/>
 </snippets>
</snippetsTree>
